Drupal.behaviors.print = function(context) {window.print();window.close();}>
Rosetta Defaults on Payment to Prometheus, Faces Bankruptcy
December 01, 2011
Rosetta Defaults on Payment to Prometheus, Faces Bankruptcy
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Rosetta Staves off Bankruptcy with Payment to Former Marketing Partner Prometheus
December 8, 2011 / Gene Silencing News
Rosetta Stock Rises on Reverse Stock Split, Kidney Test Launch, Medicare Coverage of CUP Dx
May 17, 2012 / Gene Silencing News
With Just Two Months' Cash on Hand, Rosetta Genomics Again Facing Bankruptcy
April 5, 2012 / Gene Silencing News
Rosetta to Delay Certain miRNA Diagnostics as It Markets Certain Others Itself
April 7, 2011 / Gene Silencing News
Rosetta Regains US Rights to miRNA Cancer Diagnostics, Addresses QC Issue at Diagnostics Lab
December 2, 2010 / Gene Silencing News